BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18537101)

  • 1. Genetic analysis of the soluble epoxide hydrolase gene, EPHX2, in subclinical cardiovascular disease in the Diabetes Heart Study.
    Burdon KP; Lehtinen AB; Langefeld CD; Carr JJ; Rich SS; Freedman BI; Herrington D; Bowden DW
    Diab Vasc Dis Res; 2008 Jun; 5(2):128-34. PubMed ID: 18537101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequence variation in the soluble epoxide hydrolase gene and subclinical coronary atherosclerosis: interaction with cigarette smoking.
    Wei Q; Doris PA; Pollizotto MV; Boerwinkle E; Jacobs DR; Siscovick DS; Fornage M
    Atherosclerosis; 2007 Jan; 190(1):26-34. PubMed ID: 16545818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic epidemiology of subclinical cardiovascular disease in the diabetes heart study.
    Bowden DW; Lehtinen AB; Ziegler JT; Rudock ME; Xu J; Wagenknecht LE; Herrington DM; Rich SS; Freedman BI; Carr JJ; Langefeld CD
    Ann Hum Genet; 2008 Sep; 72(Pt 5):598-610. PubMed ID: 18460048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of associations of ten candidate coronary heart disease risk genetic variants and subclinical atherosclerosis in four US populations: the Population Architecture using Genomics and Epidemiology (PAGE) study.
    Zhang L; Buzkova P; Wassel CL; Roman MJ; North KE; Crawford DC; Boston J; Brown-Gentry KD; Cole SA; Deelman E; Goodloe R; Wilson S; Heiss G; Jenny NS; Jorgensen NW; Matise TC; McClellan BE; Nato AQ; Ritchie MD; Franceschini N; Kao WH
    Atherosclerosis; 2013 Jun; 228(2):390-9. PubMed ID: 23587283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between the EPHX2 p.Lys55Arg polymorphism and prognosis following an acute coronary syndrome.
    Oni-Orisan A; Cresci S; Jones PG; Theken KN; Spertus JA; Lee CR
    Prostaglandins Other Lipid Mediat; 2018 Sep; 138():15-22. PubMed ID: 30096423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of protein tyrosine phosphatase-N1 polymorphisms with coronary calcified plaque in the Diabetes Heart Study.
    Burdon KP; Bento JL; Langefeld CD; Campbell JK; Carr JJ; Wagenknecht LM; Herrington DM; Freedman BI; Rich SS; Bowden DW
    Diabetes; 2006 Mar; 55(3):651-8. PubMed ID: 16505227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of alpha2-Heremans-Schmid glycoprotein polymorphisms with subclinical atherosclerosis.
    Lehtinen AB; Burdon KP; Lewis JP; Langefeld CD; Ziegler JT; Rich SS; Register TC; Carr JJ; Freedman BI; Bowden DW
    J Clin Endocrinol Metab; 2007 Jan; 92(1):345-52. PubMed ID: 17062776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphism of the soluble epoxide hydrolase is associated with coronary artery calcification in African-American subjects: The Coronary Artery Risk Development in Young Adults (CARDIA) study.
    Fornage M; Boerwinkle E; Doris PA; Jacobs D; Liu K; Wong ND
    Circulation; 2004 Jan; 109(3):335-9. PubMed ID: 14732757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study.
    Lee CR; North KE; Bray MS; Fornage M; Seubert JM; Newman JW; Hammock BD; Couper DJ; Heiss G; Zeldin DC
    Hum Mol Genet; 2006 May; 15(10):1640-9. PubMed ID: 16595607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A hypothesis-driven study to comprehensively investigate the association between genetic polymorphisms in EPHX2 gene and cardiovascular diseases: Findings from the UK Biobank.
    Zhu X; Li Y; Yu T; Li S; Chen M
    Gene; 2022 May; 822():146340. PubMed ID: 35183688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma Levels of Soluble Interleukin-2 Receptor α: Associations With Clinical Cardiovascular Events and Genome-Wide Association Scan.
    Durda P; Sabourin J; Lange EM; Nalls MA; Mychaleckyj JC; Jenny NS; Li J; Walston J; Harris TB; Psaty BM; Valdar W; Liu Y; Cushman M; Reiner AP; Tracy RP; Lange LA
    Arterioscler Thromb Vasc Biol; 2015 Oct; 35(10):2246-53. PubMed ID: 26293465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinase-3 gene polymorphism (rs3025058) affects markers atherosclerosis in type 2 diabetes mellitus.
    Pleskovič A; Letonja MŠ; Vujkovac AC; Starčević JN; Caprnda M; Curilla E; Mozos I; Kruzliak P; Prosecky R; Petrovič D
    Vasa; 2017 Aug; 46(5):363-369. PubMed ID: 28521653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between polymorphisms of CYP2J2 and EPHX2 genes and risk of coronary artery disease.
    Xu Y; Ding H; Peng J; Cui G; Liu L; Cianflone K; Wang DW
    Pharmacogenet Genomics; 2011 Aug; 21(8):489-94. PubMed ID: 21642892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphism rs2073618 of the osteoprotegerin gene as a potential marker of subclinical carotid atherosclerosis in Caucasians with type 2 diabetes mellitus.
    Pleskovič A; Ramuš SM; Pražnikar ZJ; Šantl Letonja M; Cokan Vujkovac A; Gazdikova K; Caprnda M; Gaspar L; Kruzliak P; Petrovič D
    Vasa; 2017 Aug; 46(5):355-362. PubMed ID: 28593808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble P-selectin, SELP polymorphisms, and atherosclerotic risk in European-American and African-African young adults: the Coronary Artery Risk Development in Young Adults (CARDIA) Study.
    Reiner AP; Carlson CS; Thyagarajan B; Rieder MJ; Polak JF; Siscovick DS; Nickerson DA; Jacobs DR; Gross MD
    Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1549-55. PubMed ID: 18535285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of rs11780592 Polymorphism in the Human Soluble Epoxide Hydrolase Gene (EPHX2) with Oxidized LDL and Mortality in Patients with Diabetic Chronic Kidney Disease.
    Roumeliotis S; Roumeliotis A; Stamou A; Panagoutsos S; Manolopoulos VG; Tsetsos F; Georgitsi M; Liakopoulos V
    Oxid Med Cell Longev; 2021; 2021():8817502. PubMed ID: 34040693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The soluble epoxide hydrolase gene harbors sequence variation associated with susceptibility to and protection from incident ischemic stroke.
    Fornage M; Lee CR; Doris PA; Bray MS; Heiss G; Zeldin DC; Boerwinkle E
    Hum Mol Genet; 2005 Oct; 14(19):2829-37. PubMed ID: 16115816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E Gene Polymorphism and Subclinical Carotid Atherosclerosis: The Northern Manhattan Study.
    Doliner B; Dong C; Blanton SH; Gardener H; Elkind MSV; Sacco RL; Demmer RT; Desvarieux M; Rundek T
    J Stroke Cerebrovasc Dis; 2018 Mar; 27(3):645-652. PubMed ID: 29103864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of ethnicity and sex on subclinical cardiovascular disease: the Diabetes Heart Study.
    Freedman BI; Hsu FC; Langefeld CD; Rich SS; Herrington DM; Carr JJ; Xu J; Bowden DW; Wagenknecht LE
    Diabetologia; 2005 Dec; 48(12):2511-8. PubMed ID: 16261310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heritability of carotid artery intima-medial thickness in type 2 diabetes.
    Lange LA; Bowden DW; Langefeld CD; Wagenknecht LE; Carr JJ; Rich SS; Riley WA; Freedman BI
    Stroke; 2002 Jul; 33(7):1876-81. PubMed ID: 12105369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.